RAS MUTATION

Clinical trials for RAS MUTATION explained in plain language.

Never miss a new study

Get alerted when new RAS MUTATION trials appear

Sign up with your email to follow new studies for RAS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Terminated 1

New drug combo targets Hard-to-Treat cancers with RAS mutations

Disease control Not yet recruiting

This study tests an experimental oral drug called GFH276 combined with either cetuximab or standard chemotherapy in people with advanced solid tumors or pancreatic ductal adenocarcinoma (PDAC) that have a RAS mutation. The goal is to see if the combination is safe, tolerable, and…

Matched conditions: RAS MUTATION

Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control

Last updated Jul 02, 2026 06:00 UTC

RAS MUTATION

Get alerted when new RAS MUTATION trials appear

New drug combo targets Hard-to-Treat cancers with RAS mutations